Clinical Trials & Studies

The process of drug development begins in the laboratory, with years of experiments that test new approaches to treatment, first in the test tube, then in living systems or models. These stages are known as “preclinical” research. If successful, Food and Drug Administration approval is sought to begin clinical trials which involve patients.

To view more information on a specific cystic fibrosis clinical trial listed below, click on the trial of interest and follow the link to a brief description. The trial descriptions found on these pages appear for informational purposes only—to generate a picture of the broad spectrum of clinical research projects that are underway.

More detailed descriptions are provided of those trials for which individual institutions have sought and obtained Institutional Review Board approval to post advertisements.

On this page:

• Protein Rescue & Ion Transport Therapies
• Anti-inflammatory Therapies
• Anti-infection Therapies
• Nutritional/GI Therapies
• Mucus Clearance and Regulatory Therapies
• Observational Studies

Protein Rescue & Ion Transport Therapies

back to top

Nutritional/GI Therapies

back to top

Mucus Clearance and Regulatory Therapies

back to top

Observational Studies

• Phase 1 Study of Progression of CF Lung Disease as Viewed by CT Imaging
• Air Pollution and Genotype Effects in CF
• Changes in Lung Structure and Function in Children With CF
• Measuring Inflammation and Infection in the Breath of Children With CF
• Quality of Life Assessment in CF After Lung Transplant
• Detecting Early Lung Disease
• Spirometry As an Outcome Measure in Preschool Children With CF
• Antibiotic Resistance in CF
• Mucus Regulation and Acute Exacerbations of CF Lung Disease
• The Role of Viruses in CF Airway Infections
• Validation of Protein Biomarkers in CF
• Effects of Nutrition and Lung Disease On Growth In Preschoolers With CF

Updated 03/13/07

back to top